LYEL — Lyell Immunopharma, Inc.
10 mentions in the last 24 hours · 0.05% of all mentions
Why people talked about LYEL (2026-11-05)
- Lyell Immunopharma announced Q3 2026 financial results on November 4, 2026.
- The company raised $80 million through a private placement of common stock.
- Shares surged 44% following the capital raise and positive data for Ronde-cel.
| Bluesky | 5 | community |
| GDELT | 2 | news |
| SEC EDGAR 8-K | 2 | filings |
| RSS Bundle | 1 | news |